These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37058449)

  • 1. Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies.
    Lee SA; Lee HJ; Suh BC; Shin HY; Kim SW; Yoon BA; Choi YC; Park HJ
    PLoS One; 2023; 18(4):e0284409. PubMed ID: 37058449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies.
    Ikenaga C; Findlay AR; Goyal NA; Robinson S; Cauchi J; Hussain Y; Wang LH; Kershen JC; Beson BA; Wallendorf M; Bucelli RC; Mozaffar T; Pestronk A; Weihl CC
    Ann Clin Transl Neurol; 2021 Mar; 8(3):571-578. PubMed ID: 33556224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
    Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
    Front Immunol; 2019; 10():745. PubMed ID: 31024569
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
    Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.
    Goyal NA; Cash TM; Alam U; Enam S; Tierney P; Araujo N; Mozaffar FH; Pestronk A; Mozaffar T
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):373-8. PubMed ID: 25857661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.
    Lloyd TE; Christopher-Stine L; Pinal-Fernandez I; Tiniakou E; Petri M; Baer A; Danoff SK; Pak K; Casciola-Rosen LA; Mammen AL
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):66-71. PubMed ID: 25892010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.
    Lloyd TE; Pinal-Fernandez I; Michelle EH; Christopher-Stine L; Pak K; Sacktor N; Mammen AL
    Neurology; 2017 Apr; 88(15):1454-1460. PubMed ID: 28283597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases.
    Diederichsen LP; Iversen LV; Nielsen CT; Jacobsen S; Hermansen ML; Witting N; Cortes R; Korsholm SS; Krogager ME; Friis T
    Muscle Nerve; 2023 Jul; 68(1):73-80. PubMed ID: 37177880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
    Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M
    Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis.
    Lucchini M; Maggi L; Pegoraro E; Filosto M; Rodolico C; Antonini G; Garibaldi M; Valentino ML; Siciliano G; Tasca G; De Arcangelis V; De Fino C; Mirabella M
    Cells; 2021 May; 10(5):. PubMed ID: 34068623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel myositis-associated antibody directed against cortactin.
    Labrador-Horrillo M; Martínez MA; Selva-O'Callaghan A; Trallero-Araguás E; Grau-Junyent JM; Vilardell-Tarrés M; Juarez C
    Autoimmun Rev; 2014 Oct; 13(10):1008-12. PubMed ID: 25182205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
    Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
    Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.
    Kramp SL; Karayev D; Shen G; Metzger AL; Morris RI; Karayev E; Lam Y; Kazdan RM; Pruijn GJ; Saschenbrecker S; Dähnrich C; Schlumberger W
    Auto Immun Highlights; 2016 Dec; 7(1):16. PubMed ID: 27858337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis.
    Yamashita S; Tawara N; Sugie K; Suzuki N; Nishino I; Aoki M
    J Neurol Sci; 2024 Sep; 464():123164. PubMed ID: 39126732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report.
    Takamiya M; Takahashi Y; Morimoto M; Morimoto N; Yamashita S; Abe K
    eNeurologicalSci; 2019 Sep; 16():100204. PubMed ID: 31517073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.